Overall severe morbidity after chemo-radiotherapy and MRI guided adaptive brachytherapy in locally advanced cervical cancer: results from the EMBRACE-I study.

This report assesses severe morbidity from the largest prospective study on CRT and IGABT for LACC to date. Severe late morbidity was limited per endpoint and organ category, but considerable when aggregated across organs and all endpoints. The late morbidity results in the XXX study compare favorably with published literature on standard radiograph based BT for GI morbidity, vaginal morbidity and fistulas.